Cargando…

Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile

Clostridium difficile is a leading cause of antibiotic-associated diarrhea, and a significant etiologic agent of healthcare-associated infections. The mechanisms of attachment and host colonization of C. difficile are not well defined. We hypothesize that non-toxin bacterial factors, especially thos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merrigan, Michelle M., Venugopal, Anilrudh, Roxas, Jennifer L., Anwar, Farhan, Mallozzi, Michael J., Roxas, Bryan A. P., Gerding, Dale N., Viswanathan, V. K., Vedantam, Gayatri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827033/ https://www.ncbi.nlm.nih.gov/pubmed/24265687 http://dx.doi.org/10.1371/journal.pone.0078404

Ejemplares similares

An Engineered Synthetic Biologic Protects Against Clostridium difficile Infection
por: Vedantam, Gayatri, et al.
Publicado: (2018)

A Clostridium difficile Cell Wall Glycopolymer Locus Influences Bacterial Shape, Polysaccharide Production and Virulence
por: Chu, Michele, et al.
Publicado: (2016)

Clostridioides difficile S-Layer Protein A (SlpA) Serves as a General Phage Receptor
por: Royer, Alexia L. M., et al.
Publicado: (2023)

Low-toxin Clostridioides difficile RT027 strains exhibit robust virulence
por: Anwar, Farhan, et al.
Publicado: (2022)

Current State of Clostridium difficile Treatment Options
por: Venugopal, Anilrudh A., et al.
Publicado: (2012)

Phylogenomic analysis of Clostridioides difficile ribotype 106 strains reveals novel genetic islands and emergent phenotypes
por: Roxas, Bryan Angelo P., et al.
Publicado: (2020)

The Clostridium difficile Protease Cwp84 Modulates both Biofilm Formation and Cell-Surface Properties
por: Pantaléon, Véronique, et al.
Publicado: (2015)

A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor
por: Whittle, M. J., et al.
Publicado: (2022)

Receptor binding protein of prophage reversibly recognizes the low-molecular weight subunit of the surface-layer protein SlpA in Clostridioides difficile
por: Phetruen, Tanaporn, et al.
Publicado: (2022)

Purification and characterization of DR_2577 (SlpA) a major S-layer protein from Deinococcus radiodurans
por: Farci, Domenica, et al.
Publicado: (2015)

The Alternative Sigma Factor SigL Influences Clostridioides difficile Toxin Production, Sporulation, and Cell Surface Properties
por: Clark, Andrew E., et al.
Publicado: (2022)

Toxin B is essential for virulence of Clostridium difficile
por: Lyras, Dena, et al.
Publicado: (2009)

Anti-virulence strategies for Clostridioides difficile infection: advances and roadblocks
por: Stewart, David, et al.
Publicado: (2020)

Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations
por: Roxas, Jennifer Lising, et al.
Publicado: (2018)

Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response
por: Maseda, Damian, et al.
Publicado: (2019)

Identification of Novel Pathogenicity Loci in Clostridium perfringens Strains That Cause Avian Necrotic Enteritis
por: Lepp, Dion, et al.
Publicado: (2010)

Correction: Identification of Novel Pathogenicity Loci in Clostridium perfringens Strains That Cause Avian Necrotic Enteritis
por: Lepp, Dion, et al.
Publicado: (2010)

The Challenging Conundrum of Diagnosing and Managing Clostridium difficile Infection
por: Gerding, Dale N., et al.
Publicado: (2017)

Biofilm Structures in a Mono-Associated Mouse Model of Clostridium difficile Infection
por: Soavelomandroso, Anna P., et al.
Publicado: (2017)

Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance
por: Gerding, Dale N, et al.
Publicado: (2014)

Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside
por: Gerding, Dale N., et al.
Publicado: (2018)

Spore Formation and Toxin Production in Clostridium difficile Biofilms
por: Semenyuk, Ekaterina G., et al.
Publicado: (2014)

Prevalence of diagnostically-discrepant Clostridioides difficile clinical specimens: insights from longitudinal surveillance
por: Anwar, Farhan, et al.
Publicado: (2023)

Enteropathogenic Escherichia coli regulates host-cell mitochondrial morphology
por: Roxas, Jennifer Lising, et al.
Publicado: (2022)

Toxinotype V Clostridium difficile in Humans and Food Animals
por: Jhung, Michael A., et al.
Publicado: (2008)

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies
por: Soriano, Melinda M., et al.
Publicado: (2014)

Multihospital Outbreak of Clostridium difficile Infection, Cleveland, Ohio, USA
por: Jump, Robin L.P., et al.
Publicado: (2010)

Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
por: Figueroa, Iris, et al.
Publicado: (2012)

The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases
por: Olsen, Margaret A., et al.
Publicado: (2016)

The Relative Role of Toxins A and B in the Virulence of Clotridioides difficile
por: Skinner, Andrew M., et al.
Publicado: (2020)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

A Simulation-Based Assessment of Strategies to Control Clostridium Difficile Transmission and Infection
por: Rubin, Michael A., et al.
Publicado: (2013)

Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis
por: Dubberke, Erik R., et al.
Publicado: (2016)

Significance analysis of microarray for relative quantitation of LC/MS data in proteomics
por: Roxas, Bryan AP, et al.
Publicado: (2008)

An assessment of false discovery rates and statistical significance in label-free quantitative proteomics with combined filters
por: Li, Qingbo, et al.
Publicado: (2009)

497. Identification of Patients at Risk of Clostridium difficile Infection for Enrollment in Vaccine Clinical Trials
por: Stevens, Vanessa, et al.
Publicado: (2018)

Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of Diagnosis
por: Bauer, Martijn P., et al.
Publicado: (2012)

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
por: Gerding, Dale N, et al.
Publicado: (2018)

Epidemiologic Trends in Clostridium difficile Isolate Ribotypes in United States from 2010 to 2014
por: Snydman, David R, et al.
Publicado: (2017)

Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection
por: Dubberke, Erik R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e140dcdvu21mqp7la7u0hc6pv4